C.C.No.382/2008 Dt.20.04.2023 Page 1 of 12 I AMM -cum-
I AJCJ, VSP
IN THE COURT OF I ADDL., METROPOLITAN MAGISTRATE:
VISAKHAPATNAM
Present: Sri G.Sai Krishna, I Addl., Metropolitan Magistrate, Visakhapatnam
Thursday, the 20th day of April, 2023
Calender Case No.382/2008
Between:
State of Andhra Pradesh, Represented by Drugs Inspector, Visakhapatnam …Complainant
And:
A-1: M/s Pharmaids Pharmaceuticals Ltd., Kondamadugu Village, Bibinagar Manda, Nalgonda District Represented by Dr.Ghisulal Jain, Managing Director.
A-2: Dr.Ghisulal Jain, S/o late B.M.Lalwani Age 45 years, Managing Director, M/s Pharmaids Pharmaceuticals Ltd., 4-3-55, K.S.Lane, Sultan bazaar, Hyderabad.
A-3: Mr.Subhash B.Lalwani, S/o Late B.M.Lalwani, age 35 years, Director, M/s Pharmaids Pharmaceuticals Ltd.,4-3- 55, K.S.Lane, Sultan bazaar, Hyderabad.
A-4: Mr.Hasunukh Jain, S/o late B.M.Lalwani, agee 40 years, Director, 4-3-55, K.S.Lane, Sultan bazaar, Hyderabad.
…Accused
This Case is coming on 12.04.2023 before me for final hearing in the presence of Smt.R.Vani, Assistant Public Prosecutor for the
State/Complainant and of Sri M.Govinda, Advocate for Accused and having stood over for consideration till this day, this Court delivered the following:
C.C.No.382/2008 Dt.20.04.2023 Page 2 of 12 I AMM -cum-
I AJCJ, VSP
J U D G M E N T
The Drugs Inspector, Visakhapatnam filed a private complaint against the accused A1 to A4 for the offence punishable under section 27(d) of Drugs and Cosmetics Act, 1940.
2.The gist of complaint is as follows:
The A.1 is a Drug Manufacturing Company and A.2, A.3 and A.4 represents the A.1. On 06.02.2002, LW.1/A.Gowri Shankar, Drug Inspector,
Visakhapatnam picked up sample Solbutamol tablet manufactured by A1 from Central Drugs Stores, APHMHIDC, Visakhapatnam, Nakkavanipalem in the presence of LW.2/R.Simhachalam, Pharmacist. The LW.1/A.Gowri
Shankar, issued Form-17 to the LW.2/R.Simhachalam, Pharmacist at the time of pick up of sample. Then one portion of the sealed sample was sent to
Government Analyst, as per Form-18 on the same date. Thereafter, the
Government Analyst i.e. Drugs Control, Hyderabad issued Form-13 report to the LW.3/Ravi Uday Bhaskar declaring the tablet as “not of standard quality”.
As the sample does not conform with Solbutamol tablet, LW.3/Ravi Uday
Bhaskar addressed a letter to Executive Engineer, Central Drug Store under section 18 A of Drugs and Cosmetics Act 1940. In turn, on 19.12.2002, the
Executive engineer submitted sealed copy of invoice dated 03.01.2002 of A1 showing purchase of the above said tablet from A1. Then LW.3/Ravi Uday
Bhaskar addressed a letter on 26.12.2002 to A1 along with form-13 analyst report copy and sealed third part of sample through registered post with
C.C.No.382/2008 Dt.20.04.2023 Page 3 of 12 I AMM -cum-
I AJCJ, VSP
acknowledgment due. The letter was delivered on 30.12.2002. On 24.02.2002, LW.3/Ravi Uday Bhaskar received letter from the A1, wherein the
A1 questioned the test conducted by Government Analyst. LW.3/Ravi Uday
Bhaskar did not send the second portion of the sample to Director of Kolkata as it did not challenge the report within 28 days.
b) The A.1 represented by A.2 to A4 sold not of standard quality of Solbutamol tablet in violation of section 18(a)(i) of Drugs and Cosmetics
Act, 1940 punishable under section 27 (d) of the said Act.
3.Upon perusal of the private complaint and documents, the Court was satisfied that there is a prima facie case against the Accused for offence punishable under section 18(a) (I) and section 27(d) of Drugs and
Cosmetics Act, 1940. Hence, the Court took cognizance of offence under section 18(a) (I) and section 27(d) of Drugs and Cosmetics Act, 1940 against the Accused.
4. The case was transferred from the Honourable Chief
Metropolitan Magistrate’s court, Visakhapatnam as per proceedings of the
Honorable Metropolitan Sessions Judge’s court, Visakhapatnam in
Dis.No.1021/2008, dt.27.10.2008 to this court.
5.Summons was issued to the Accused. Upon receipt of summons, the Accused appeared before the Court. Copies of the complaint and documents were furnished to the Accused as per section 207 Cr.P.C.
Subsequently, The Accused were examined under Section 251 Cr.P.C for the offence under section 18(a) (I) and section 27(d) of Drugs and Cosmetics
C.C.No.382/2008 Dt.20.04.2023 Page 4 of 12 I AMM -cum-
I AJCJ, VSP
Act, 1940 against the Accused and the sum and substance of complaint and documents was read over and explained to the Accused in English/Telugu, for which, they pleaded not guilty and claimed to be tried.
6.On behalf of the prosecution, LW.1/A.Gowri Shankar, was examined as PW.1. Ex.P1 , P3 and M,O,1 were marked through PW.1.
LW.2/Simhachalam, Pharmacist was examined as PW.2. LW.3/Ravi Udaya
Bhaskar, Drug Inspector was examined as PW.3. Exs.P3 to P16 were marked through PW.3. Ex.P1 is Form No.17, dated 06.02.2002, Ex.P2 is Form No.18,
dated 06.02.2002.Ex.P3 is the Form-13, the report of Government Analyst
vide No.2904/DCL/2002, dated 28.11.2002, Ex.P4 is the 18-A Notice
R.C.No.497, dated 17.12.2002, Ex.P5 is the acknowledgment on Ex.P4, Ex.P6
is the Letter No.1/dated 19.12.2002 of E.E, Ex.P7 is the Invoice No.1037,
dated 03.01.2002, Ex.P8 is the Distribution particulars. Ex.P9 is the letter RC
No.497, dated 26.12.2002. Ex.P10 is the postal acknowledgment No.5234,
Ex.P11 is the letter dated 03.02.2003 of A.1’s firm. Ex.P12 is the batch record of sample drug, Ex.P13 is the Finished product analytical report,
Ex.P.14 is the Form-26 of A.1’s Firm. Ex.P15 is affidavit of A1’s firm, Ex.P16 is letter dated 01.02.2003. MO.1 is the sealed packet or cover consisting 50 tablets of Solbutamol.
7.On completion of the prosecution evidence, the incriminating prosecution evidence was read over and explained to the accused in English/
Telugu as per section 313 Cr.P.C. The Accused denied the prosecution evidence and reported no defence evidence.
C.C.No.382/2008 Dt.20.04.2023 Page 5 of 12 I AMM -cum-
I AJCJ, VSP
8.Perused the private complaint, documents and evidence on record. Heard both sides. The following points arise for determination of the
Court:
1.Whether the Accused manufactured not of standard quality Solbutamol Tablet for the purpose of sale and distribution in violation of section 18(a) (i) of the Drugs and Cosmetics Act 1940.?
2.Whether the prosecution proved the guilt of the Accused beyond all reasonable doubt for the offence under section 27(d) of Drugs and Cosmetics Act, 1940.?
9.POINT No.1 :
As per the chief examination of PW.1 on 06.02.2002, when he was working as Drug Inspector in Visakhapatnam, he visited the Central
Drugs Stores, APHMHIDC situated in Nakkavanipalem, Visakhapatnam and at that time, PW.2 (Pharmacist) was present in the Store. PW.1 further deposed that upon suspicion, he lifted among other tablets, Solbutamol sample of 250 tablets. He further deposed that the sample 250 tables were divided into four parts, consisting of three parts each 50 tablets and one part 100 tablets. PW.1 further deposed that the samples were taken into a polythene cover and thereafter slips were pasted on them and then the signature of Pharmacist was obtained on them. It is stated that the said transaction was reduced to writing in Form-17 and one of the same was served on the Pharmacist.
10.During the cross examination, it is elicited from PW.1 that he did not send any intimation to the Manufacturer about the samples collected.
C.C.No.382/2008 Dt.20.04.2023 Page 6 of 12 I AMM -cum-
I AJCJ, VSP
The PW.2 deposed in chief examination that on 06.02.2002 the PW.1 visited the Central Drug Store where PW.2 was working and in his presence, PW.1 took samples of 4 drugs including Solbutamol tablets. PW.2 admitted his signature on Form-17 issued to him by the PW.1. PW.2 identified his signature on Ex.P.1. during the cross examination, PW.2 admitted that
Central Drug Stores is a Government organization and it maintains inward and outward stock register and the samples obtained by the Drug Inspector are noted in the register. PW.2 stated that the PW.1 did not seize any register from the Drug Store.
11.The contents of Form-17 marked through PW.1 is in the prescribed format and its contains the details of the Drugs and Solbutamol tablets picked up at Central Drug Stores on 06.02.2002. Form-17 also bears admitted signature of the PW.2. M.O.1 is one of the four parts of the samples of Solbutamol tablet marked through PW.1. The evidence of PW.2 corroborates with the evidence of PW.1 on all material particulars relating to the visit of PW.1 to the Drugs Stores, pick up of all samples and issuance of
Form-13. Although, the defence counsel brought out important fact relating to non collection of inward and outward register, that alone does not affect the case of the prosecution in light of Form-17 and the evidence of PW.2.
From the above evidence of PW.1 and PW.2 and Ex.P1 and M.O.1, it can be said that prosecution proved beyond reasonable doubt that on 06.02.2002, the PW.1 lifted the samples of Solbutamol tablets from the Central Drug
Stores, Nakkavanipalem under Form-17.
C.C.No.382/2008 Dt.20.04.2023 Page 7 of 12 I AMM -cum-
I AJCJ, VSP
12.As per the PW.1, in his chief examination on 06.02.2002, itself
PW.1 prepared Form-18 and sent the samples of 100 tablets to the
Government Analyst, Hyderabad for Analysis. Ex.P2 is a Form-18, PW.3 who succeeded the PW.1 in office deposed that on 01.06.2021 he received report of Government analyst under Form-13. Ex.P3 is the analysis report. Ex.P.11 which is admittedly the letter addressed by the A1 to the Drug Inspector in reply to Ex.P9 does not dispute the facts regarding the lifting of sample.
Further, Ex.P3 shows that Ex.P2 duly received by the Government analyst and he analyzed the sample of 100 tablets. Therefore, the said fact regarding receipt of Government analyst report with respect to the sample sent to the Analysis stands proved.
13.PW.3 deposed in his chief examination that after receipt of Ex.P3, himself addressed a letter to the Executive Engineer, APHMHIDC under Form- 18 (a)/ under Ex.P4 requesting certain details including the details of the manufacture of the sample drugs. Ex.P4 is the letter dated19.12.2002 addressed by PW.3 to Executive engineer. Ex.P5 is the acknowledgment to
Ex.P4. Ex.P6 letter was addressed by the Executive Engineer to the PW.3 providing details of Manufacture of A1 including Ex.P6 and P7 invoices and the distribution particulars. As per the evidence of PW.3, on receipt of Ex.P6 details he forwarded one sample of the Drug and copy of the Government analyst report to the A1 under Ex.P9. Ex.P10 was filed in proof of service of the said letters/intimation dated 26.12.2002 on 30.12.2002, Ex.P6 bears the date of delivery as 30.12.2002. During the cross examination, PW.3 admitted that Ex.P11 states that Ex.9 was received by A1 on 17.01.2003.
C.C.No.382/2008 Dt.20.04.2023 Page 8 of 12 I AMM -cum-
I AJCJ, VSP
Ex.P11 also refers to the Ex.P9 as received on 17.01.2003. However, the accused did not adduce any evidence to prove that Ex.P9 was received by A1 on 17.01.2003 and not on 30.12.2002. In this regard, the prosecution filed
Ex.P10 which amply proves that the date of service of Ex.P9 on A1 is 30.12.2002.
14.PW.3 in his evidence stated that the A1 challenged the report of
Government analyst/Ex.P3 vide letter dated 03.02.2003/ Ex.P11. PW.1 stated that as the said letter was received by the PW.3 on 24.02.2003 i.e.
much after the 28 days time frame from the date of receipt, he did not sent the sample drug lying with him to Central Drug laboratory for analysis.
Perusal of Ex.P11 discloses that it was dated 03.02.2003. The 28 days period from the date of receipt of Ex.P9 i.e. 30.12.2002 expires on January 28th , 2003. Therefore, the defence of the accused that they challenged the report of Government analyst within time is not proved. Even taking into account the receipt, date of Ex.P9 i.e. 17.01.2003 (As per Ex.P11), the 28 days period expires by February, 15th, 2003. According to PW.3, they received the reply of A1 on 24.02.2003. Therefore, looking from any point of view, it can be said that A1 sent Ex.P11 challenging Ex.P3 much after the time prescribed under section 25 of the Drugs and Cosmetics Act. In such a case, it can be said that Ex.P3 has become final and conclusive as per section 25 of the said
Act.
15.From the above discussion, it can be said that the prosecution proved the lifting of the sample under Ex.P1, the submission of the sample to
C.C.No.382/2008 Dt.20.04.2023 Page 9 of 12 I AMM -cum-
I AJCJ, VSP
Government Analyst, Hyderabad, the opinion of Government analyst that the sample picked up is “not of standard quality”. Ex.P11 which is admitted by the accused proves that the A1 does not dispute the facts regarding the manufacture of the sample of the Drug from its premises, its distribution to
Central Drug Stores. The only point disputed by A1 is regarding test method adopted by the Government analyst. Further, Ex.P7 and Ex.P8 proves that the A1 sold and distributed the sample drug to the Central Drug Stores.
From the above evidence including Ex.P3 report, it can be said that the prosecution proved the guilt of the accused beyond reasonable doubt and that A1 sold and distributed the sample drug which is of not standard quality in violation of Section 18(a)(i) of the Drugs and Cosmetics Act. Accordingly,
Point No.1 is answered in favour the prosecution and against the accused.
POINT NO.2:
16.Ex.P.14 was filed by the prosecution through PW.3 to prove that
A2 to A4 represent the A1 as the Managing Director and Directors respectively. The defence counsel during cross-examination suggested to
PW.3 that Exs.P14 and P15 are not valid documents. There is nothing on record adduced by the accused to show why Ex.P14 and P15 are not valid documents. Hence, it can be said that A2 to A4 were the persons in-charge of A1 at the time of Manufacture. sale and distribution of “not of standard quality” drug. Hence, A1 to A4 are hereby found guilty for the offence punishable under section 27 (d) of Drugs and Cosmetics Act, 1940. Hence,
Point No.2 is answered in favour of the prosecution and against the accused.
C.C.No.382/2008 Dt.20.04.2023 Page 10 of 12 I AMM -cum-
I AJCJ, VSP
17. In the result, the accused A.1 is hereby found guilty for the offence punishable under Section 27 (d) of Drugs and Cosmetics Act 1940 and it is hereby convicted under Section 255 (2) Cr.P.C for the offence under
Section 27 (d) of Drugs and Cosmetics Act 1940.
18.In the result, the accused A.2 to A.4 are hereby found guilty for the offence punishable under Section 27 (d) of Drugs and
Cosmetics Act 1940 and they are hereby convicted under Section 255 (2)
Cr.P.C for the offence under Section 27 (d) of Drugs and Cosmetics Act 1940.
M.O.1 shall be destroyed after expiry of Six months from the date of this judgment.
Dictated to the Stenographer, transcribed by her, corrected and pronounced by me in
the open Court this the 20th day of April, 2023.
Sd/G. Sai Krishna
I ADDL. METROPOLITAN MAGISTRATE,
VISAKHAPATNAM
19. Having regard to the facts and circumstances of the case and considering the nature of offence, this Court is of the opinion that it is not a fit case to extend the benefit provided under Probation of Offenders Act.
Special reasons for reduced sentence:
20.Heard the defence counsel and accused on point of sentence.
The defence counsel submitted that A2 is suffering with Heart ailments and the case was pending from the year 2008 and the Drug Inspector took the samples in the year 2002.
C.C.No.382/2008 Dt.20.04.2023 Page 11 of 12 I AMM -cum-
I AJCJ, VSP
21.Having considered the submission of the accused, the age of all the accused, the gravity of the offence, the time taken for conduct of trial, the health condition of A.2, this court finds that below sentence will commensurate with circumstances of the case.
22. In the result, A.1 which is a Company is hereby sentenced to pay fine of Rs.10,000/- (Rupees Ten thousand only) for the offence under section 27(d) read with Section 34 of the Drugs and Cosmetics Act and by application of law laid down by the Honourable Supreme Court in M.V.Javali
Vs. Mahajan Bore-well & Company and others, dated 26-09-1997.
23.Further, accused A2 to A4 are hereby sentenced to undergo
Simple Imprisonment for a period of Six Months (6 months) each and also sentenced to pay a fine amount of Rs.10,000/-(Rupees Ten thousand only) each for the offence punishable 27 (d) of Drugs and Cosmetics Act 1940 and in default of payment of fine amount, the accused shall suffer
Simple Imprisonment for a period of Two months.
24. The Accused are informed of their right to file appeal against the
Calendar and Judgment of this court. When Accused are asked about their means to prefer an appeal, they stated that they are having means to engage a counsel in appellate Court.
Dictated to the Stenographer, transcribed by her, corrected and pronounced by me in
the open Court this the 20th day of April 2023.
Sd/G. Sai Krishna
I ADDL. METROPOLITAN MAGISTRATE,
VISAKHAPATNAM
C.C.No.382/2008 Dt.20.04.2023 Page 12 of 12 I AMM -cum-
I AJCJ, VSP
APPENDIX OF EVIDENCE
Witnesses Examined
For Prosecution:For Defence:
PW.1: A.Gowri Shankar- NONE -
PW.2: R.Simhachalam
PW.3: Ravi Uday Bhaskar
Exhibits Marked
For Prosecution: Ex.P1/--Form No.17, dated 06.02.2002,
Ex.P2/--Form No.18, dated 06.02.2002.
Ex.P3/--Form-13, the report of Government Analyst vide No.2904/DCL/2002, dated 28.11.2002,
Ex.P4/--18-A Notice R.C.No.497, dated 17.12.2002,
Ex.P5/--Acknowledgment on Ex.P4,
Ex.P6/--Letter No.1/dated 19.12.2002 of Executive Engineer,
Ex.P7/--Invoice No.1037, dated 03.01.2002,
Ex.P8/--Distribution particulars.
Ex.P9/--Letter RC No.497, dated 26.12.2002.
Ex.P10/--Postal acknowledgment No.5234,
Ex.P11/--Letter dated 03.02.2003 of A.1’s firm.
Ex.P12/--Batch record of sample drug,
Ex.P13/--Finished product analytical report,
Ex.P.14/-- Form-26 of A.1’s Firm.
Ex.P15/--Affidavit of A1’s firm,
Ex.P16/--Letter dated 01.02.2003.
For Defence:- NIL -
C.C.No.382/2008 Dt.20.04.2023 Page 13 of 12 I AMM -cum-
I AJCJ, VSP
Material objects:
MO.1/-- Sealed packet or cover consisting 50 tablets of Solbutamol .
Sd/- G.Sai Krishna
I AMM:VSP //True copy//
I ADDL. METROPOLITAN MAGISTRATE,
VISAKHAPATNAM
C.C.No.382/2008 Dt.20.04.2023 Page 14 of 12 I AMM -cum-
I AJCJ, VSP
CALENDAR AND JUDGMENT
CALENDAR CASE TRIABLE ON THE FILE OF I ADDL. METROPOLITAN MAGISTRATE,
VISAKHAPATNAM
C.C.No.382/2008
DATES OF:
1. Date of Offence : 06.02.2002 2.Date of Apprehension of Accused : 06.02.2002 :
3. Date of Taken on file : 04.08.2003
4. Date of Commencement of Trial : 01.12.2007
5. Date of Close of Trial : 16.03.2023
6. Date of Judgment : 20-04-2023
7. Explanation for delay :The case was transferred from the Honourable Chief Metropolitan Magistrate’s court, Visakhapatnam as per proceedings of the
Honorable Metropolitan Sessions Judge’s
court,Visakhapatnam,in Dis.No.1021/2008,dt.27.10.2008 to this court.
8. Name of the Complainant : The State represented by Drugs Inspector, Visakhapatnam City.
9. Name of the Accused :A-1: M/s Pharmaids Pharmaceuticals Ltd., Kondamadugu Village, Bibinagar Manda, NalgondaDistrictRepresentedby Dr.Ghisulal Jain, Managing Director.
A-2: Dr.Ghisulal Jain, S/o late B.M.Lalwani Age 45 years, Managing Director, M/s Pharmaids Pharmaceuticals Ltd., 4-3-55, K.S.Lane, Sultan bazaar, Hyderabad.
A-3: Mr.Subhash B.Lalwani, S/o Late B.M.Lalwani, age 35 years, Director, M/s Pharmaids Pharmaceuticals Ltd.,4-3-55, K.S.Lane, Sultan bazaar, Hyderabad.
A-4: Mr.Hasunukh Jain, S/o late B.M.Lalwani, agee 40 years, Director, 4-3-55, K.S.Lane, Sultan bazaar, Hyderabad.
10. Offence : U/s 27 (d) of Drugs and Cosmetics Act 1940.
11. Plea of Accused. : PLEADED NOT GUILTY.
C.C.No.382/2008 Dt.20.04.2023 Page 15 of 12 I AMM -cum-
I AJCJ, VSP
12. Finding : A1 to A4 are convicted U/s.255 (2) Cr.P.C.
13. Result : In the result, the accused A.1 is hereby found guilty for the offence punishable under Section 27 (d) of Drugs and Cosmetics Act 1940 and it is hereby convicted under Section 255 (2) Cr.P.C for the offence under Section 27 (d) of Drugs and Cosmetics Act 1940 and the accused A.2 to A.4 are hereby found guilty for the offence punishable under Section 27 (d) of Drugs and Cosmetics Act 1940 and they are hereby convicted under Section 255 (2) Cr.P.C for the offence under Section 27 (d) of Drugs and Cosmetics Act 1940. M.O.1 shall be destroyed after expiry of Six months from the date of this judgment and In the result, A.1 which is a Company is hereby sentenced to pay fine of Rs.10,000/- (Rupees Ten thousand only) for the offence under section 27(d) read with Section 34 of the Drugs and Cosmetics Act and by application of law laid down by the
Honourable Supreme Court in M.V.Javali Vs.
Mahajan Bore-well & Company and others, dated 26-09-1997 and further, accused A2 to A4 are hereby sentenced to undergo Simple Imprisonment for a period of Six Months (6 months) each and also sentenced to pay a fine amount of Rs.10,000/-(Rupees Ten thousand only) each for the offence punishable 27 (d) of Drugs and Cosmetics Act 1940 and in default of payment of fine amount, the accused shall suffer Simple Imprisonment for a period of Two months.
The Accused are informed of their right to file appeal against the Calendar and Judgment of this court. When Accused are asked about their means to prefer an appeal, they stated that they are having means to engage a counsel in appellate Court.
Sd/- G.Sai Krishna
I Addl. Metropolitan Magistrate, Visakhapatnam //True Copy//
I Addl. Metropolitan Magistrate, Visakhapatnam